Literature DB >> 21593000

Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.

Douglas S Kernodle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21593000     DOI： 10.1093/infdis/jir141

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

Review 1.  Pathogenesis of Staphylococcus aureus Bloodstream Infections.

Authors:  Lena Thomer; Olaf Schneewind; Dominique Missiakas
Journal:  Annu Rev Pathol       Date:  2016-02-25       Impact factor: 23.472

2.  Nanotoxoid Vaccines.

Authors:  Che-Ming J Hu; Liangfang Zhang
Journal:  Nano Today       Date:  2014-08-01       Impact factor: 20.722

3.  Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant Staphylococcus aureus Skin Infection.

Authors:  Fei Wang; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Soracha Thamphiwatana; Diana Dehaini; Pavimol Angsantikul; Ashley V Kroll; Zhiqing Pang; Weiwei Gao; Weiyue Lu; Liangfang Zhang
Journal:  Adv Funct Mater       Date:  2016-02-05       Impact factor: 18.808

4.  Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection.

Authors:  Sabine Rauch; Portia Gough; Hwan Keun Kim; Olaf Schneewind; Dominique Missiakas
Journal:  Infect Immun       Date:  2014-09-02       Impact factor: 3.441

Review 5.  Nanoparticle-based local antimicrobial drug delivery.

Authors:  Weiwei Gao; Yijie Chen; Yue Zhang; Qiangzhe Zhang; Liangfang Zhang
Journal:  Adv Drug Deliv Rev       Date:  2017-09-20       Impact factor: 15.470

6.  Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs.

Authors:  Hwan Keun Kim; Fabiana Falugi; Lena Thomer; Dominique M Missiakas; Olaf Schneewind
Journal:  mBio       Date:  2015-01-06       Impact factor: 7.867

7.  Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.

Authors:  Clarissa Pozzi; Katarzyna Wilk; Jean C Lee; Marina Gening; Nikolay Nifantiev; Gerald B Pier
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

Review 8.  Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform.

Authors:  Pavimol Angsantikul; Soracha Thamphiwatana; Weiwei Gao; Liangfang Zhang
Journal:  Vaccines (Basel)       Date:  2015-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.